Researchers have identified how variations in a gene called TRIO can influence brain functions and result in distinct neurodevelopmental diseases. The study, published in the journal eLife, could pave the way for future therapeutic developments.

TRIO encodes a diverse group of proteins that control the function and structure of the cytoskeleton—a cell’s internal scaffolding. Rare damaging variants in this gene have been identified in individuals with intellectual disability, autism spectrum disorder, schizophrenia, and related disorders. However, the mechanisms underlying the associations aren’t yet understood.

“It’s really extraordinary that different variants in this single gene can have such dramatically different effects on brain development and function,” says Anthony Koleske, Ph.D., Ensign Professor of Molecular Biophysics and Biochemistry at Yale School of Medicine (YSM) and the study’s senior author.

In recent years, scientists discovered something strange: When mice with Alzheimer’s disease inhale menthol, their cognitive abilities improve.

It seems the chemical compound can stop some of the damage done to the brain that’s usually associated with the disease.

In particular, researchers noticed a reduction in the interleukin-1-beta (IL-1β) protein, which helps to regulate the body’s inflammatory response – a response that can offer natural protection but one that leads to harm when it’s not controlled properly.